XTalks

MAY 2, 2024

During a midday session, Anal Dave from Dessert Holdings and David Hatch, Vice President of Digital Solutions Marketing at Neogen , showcased their digital transformation strategies in environmental testing, enhancing detection and compliance. He noted the challenge of staffing, particularly in maintaining trained and dedicated personnel.

Compliance 108

Compliance Regulation Production Containment 108

Rethinking Clinical Trials

JULY 6, 2023

Over the past several years, a variety of factors have accelerated the need for decentralized trials, including the push to make trials more accessible, the increased speed of science, the possibility of environmentally conscious trials, and the need to be flexible in a rapidly changing world.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

Drug Discovery World

OCTOBER 3, 2022

She also works on her own research following her PhD in the digitisation of scientific research, smart labs and the lab of the future, and semantic tagging of scientific data, which she has continued as part of the Physical Sciences Data Infrastructure (PSDI) Project.

Drugs 52

Drugs Scientist Bioinformatics Medicine 52

Drug Discovery World

NOVEMBER 9, 2023

Kielczewska will present: ‘Discovery of antibody-based therapeutics to challenging targets: Platform considerations’. The presentations include: Laura Sewell, Scientist, Biopharmaceutical Development, AstraZeneca, on: ‘Challenges of working with a two-faced bispecific — one size does not fit all’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Cloudbyz

JUNE 1, 2023

This allows businesses to future-proof their operations, knowing that their CRM platform won’t limit their growth or adaptation to new challenges or opportunities. Environmental Considerations: Salesforce is committed to sustainable business practices, and this extends to its data centers.

Compliance 76

Compliance Development Branding Production 76

The Pharma Data

MAY 4, 2021

In March 2021, Pfizer issued its Environmental, Social and Governance (ESG) Report for fiscal year 2020, the first of its kind for Pfizer. This study is anticipated to be the final Phase 2 study readout before a decision to progress into pivotal Phase 3 studies. Corporate Developments.

Vaccination 40

Vaccination Vaccine Production Sales 40

XTalks

FEBRUARY 14, 2023

However, the 2023 Farm Bill faces several challenges that have the potential to split Congressional members along party lines. Spending on the nutrition title alone is expected to push the price tag for the next Farm Bill to more than $1 trillion over the next ten years.

Packaging 98

Packaging Packaging Production Marketing 98